1. Home
  2. GTLB vs LIVN Comparison

GTLB vs LIVN Comparison

Compare GTLB & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GitLab Inc.

GTLB

GitLab Inc.

HOLD

Current Price

$21.58

Market Cap

3.9B

Sector

Technology

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$63.75

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTLB
LIVN
Founded
2011
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.5B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
GTLB
LIVN
Price
$21.58
$63.75
Analyst Decision
Buy
Buy
Analyst Count
29
7
Target Price
$40.96
$72.43
AVG Volume (30 Days)
6.3M
757.9K
Earning Date
03-03-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$955,224,000.00
N/A
Revenue This Year
$18.82
$9.43
Revenue Next Year
$15.95
$6.85
P/E Ratio
N/A
N/A
Revenue Growth
25.81
N/A
52 Week Low
$20.20
$32.48
52 Week High
$52.38
$71.58

Technical Indicators

Market Signals
Indicator
GTLB
LIVN
Relative Strength Index (RSI) 36.34 51.32
Support Level N/A $61.80
Resistance Level $50.49 $65.25
Average True Range (ATR) 0.98 2.11
MACD 0.18 0.15
Stochastic Oscillator 34.99 85.98

Price Performance

Historical Comparison
GTLB
LIVN

About GTLB GitLab Inc.

GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: